Targeting Phosphatidylserine Synthesis for Tumor Cell Suppression in Esophageal Squamous Cell Carcinoma and Glioblastoma
International Journal of Molecular Sciences · 13.07.2026 · 27 (14) · 6226
DOI: 10.3390/ijms27146226 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 13.07.2026. Verfasst von Yixuan Hu und 4 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Gene Expression, School of Life Sciences, Westlake University, Hangzhou 310030, China. Hauptthemen laut MEDLINE: Phosphatidylserines, Glioblastoma, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Hangzhou City Leading Innovation and Entrepreneurship Team, “Pioneer” and “Leading Goose” R&D Program of Zhejiang.
Abstract (Originalsprache)
While altered lipid metabolism is a hallmark of cancer, specific phospholipid dependencies remain poorly defined. Here, we identify phosphatidylserine synthase 1 (PTDSS1) as a targetable metabolic vulnerability in esophageal squamous cell carcinoma (ESCC) and glioblastoma (GBM). Pharmacological inhibition of PTDSS1 selectively and potently suppresses tumor growth both in vitro and in vivo. Mechanistically, PTDSS1 blockade triggers a rapid collapse of cellular phosphatidylserine (PS) and phosphatidylethanolamine (PE) pools, fundamentally disrupting endoplasmic reticulum (ER) homeostasis. This targeted lipid depletion activates a PERK-mediated autophagic response that ultimately yields to apoptosis. Clinically, pan-cancer transcriptomic analysis links elevated PTDSS1 expression to reduced overall survival across diverse malignancies. Collectively, we establish PTDSS1 as an essential maintainer of ER integrity and highlight PS biosynthesis as a viable therapeutic target for exploiting tumor-specific metabolic dependencies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Gene Expression, School of Life Sciences, Westlake University, Hangzhou 310030, China.
- Westlake Laboratory of Life Sciences and Biomedicine, Hangzhou 310024, China.
ORCID-Profile: Yixuan Hu
Förderung
- National Natural Science Foundation of China
- Hangzhou City Leading Innovation and Entrepreneurship Team
- “Pioneer” and “Leading Goose” R&D Program of Zhejiang
- Westlake Education Foundation
- Westlake Laboratory of Life Sciences and Biomedicine
Zitieren
APA
Hu, Y., Cui, Y., Xu, Z., Wu, D., & Yu, X. (2026). Targeting Phosphatidylserine Synthesis for Tumor Cell Suppression in Esophageal Squamous Cell Carcinoma and Glioblastoma. International Journal of Molecular Sciences, 27(14), 6226. https://doi.org/10.3390/ijms27146226
Vancouver
Hu Y, Cui Y, Xu Z, Wu D, Yu X. Targeting Phosphatidylserine Synthesis for Tumor Cell Suppression in Esophageal Squamous Cell Carcinoma and Glioblastoma. International Journal of Molecular Sciences. 2026;27(14):6226. doi:10.3390/ijms27146226
BibTeX
@article{Hu2026,
author = {Hu, Yixuan and Cui, Yaqi and Xu, Zeqiong and Wu, Duo and Yu, Xiaochun},
title = {Targeting Phosphatidylserine Synthesis for Tumor Cell Suppression in Esophageal Squamous Cell Carcinoma and Glioblastoma},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {14},
pages = {6226},
doi = {10.3390/ijms27146226}
}
EUVIMED